Showing results (1841-1850 of 2,000) with videos related to
Sort By:
Pageof 200
Sensors and Actuators. B, Chemical|February 6, 2023
RT-RPA-Cas12a-based assay facilitates the discrimination of SARS-CoV-2 variants of concernGuiyue Tang, Zilong Zhang, Wei Tan, et al.Bioorganic & Medicinal Chemistry|January 22, 2023
Auranofin inhibits virulence pathways in Pseudomonas aeruginosaJoey Kuok Hoong Yam, Leon Zhen Wei Tan, Ziyan Hong, et al.Obesity (Silver Spring, Md.)|January 16, 2024
Effects of time-restricted eating on intrahepatic fat and metabolic health among patients with nonalcoholic fatty liver diseaseYan Deng, Xiaoming Liu, Yuzhe Sun, et al.Drug Design, Development and Therapy|July 1, 2016
Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell lineNorlaily Mohd Ali, M Nadeem Akhtar, Huynh Ky, et al.JMIR Public Health and Surveillance|August 16, 2022
Estimating Changes in Population Size and Behavioral Characteristics in Men Who Have Sex With Men Between 2014 and 2019: Longitudinal StudyZijie Yang, Lan Wei, Wei Xie, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2025
Population-attributable fractions for modifiable risk factors across the continuum of cognitive decline: Hubei Memory and Aging Cohort StudyJuan Zhou, Feifei Hu, Xiaochang Liu, et al.American Journal of Ophthalmology|January 9, 2016
Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective StudyDaniel Shu Wei Ting, Wei Yan Ng, Si Rui Ng, et al.Experimental Eye Research|June 1, 2018
A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapiesYong Li, Joanna Marie Busoy, Ben Alfyan Achirn Zaman, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|October 27, 2007
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor modelsLajos Balogh, Shraddha S Nigavekar, Bindu M Nair, et al.Journal of Medicinal Chemistry|January 29, 2015
Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's diseasePaul B Huleatt, Mui Ling Khoo, Yi Yuan Chua, et al.Pageof 200